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A 33-year-old male patient with ipsilateral intermittent oscillopsia and blurry vision for 18 months was
found to have intorsional nystagmus of the right eye, especially when gazing at the nasal lower ﬁeld. The
oscillations improved with exercise and were aggravated by rest. An abnormal head posture, with a tilt
towards the left, and mild right superior oblique muscle paresis were noted by the prism cover test and
motility examination. Neurovascular compression was not conﬁrmed by 0.9-mm thick, high-resolution
magnetic resonance imaging with fast imaging employing steady state acquisition sequence. After
treatment with oxcarbazepine (600 mg/day), the oscillations resolved and there have been no compli-
cations during the 1-year follow-up period. Superior oblique myokymia is a rare form of nystagmus that
may cause oscillopsia and blurry vision. Oxcarbazepine, a structural derivative of carbamazepine, can be
used to successfully eliminate oscillopsia without serious adverse reaction.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Superior oblique myokymia (SOM) is an uncommon disorder; it
typically presents with intermittent ipsilateral oscillopsia, ﬁrst
described by Duane1 in 1906. The pathogenesis of this disease
entity is not fully understood. However, neurovascular compression
of the trochlear nerve may play an important role.2 Medical treat-
ment,3 extraocular surgery of involvedmuscles,4 and neurovascular
decompression of the trochlear nerve5 have been reported as
treatments for SOM. We report a case of SOM without deﬁnite
magnetic resonance imaging evidence of vascular compression; the
symptoms were successfully controlled using oxcarbazepine.
2. Case report
A 33-year-old male patient presented to our clinic with unilat-
eral intermittent oscillopsia and double vision for 18 months. The
visual symptoms were reported to partially improve with exercise
and extreme fatigue, but were aggravated at rest. The position of
the head was tilted to the left, which helped alleviate visual
symptoms. The patient had a corrected visual acuity of 20/20 iny have no ﬁnancial or non-
tter or materials discussed in
gy, National Taiwan University
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ai).
e Ophthalmologic Society of Taiwboth eyes. Motility examination showed mild updrift of the right
eye on levoversion. The prism cover test revealed small angle right
hypertropia of approximately ﬁve prism diopters. Intorsional
twitching of the right eye was observed under slit lamp examina-
tion. Intorsional nystagmus was more noticeable with the gaze to
the nasal lower ﬁeld of the right eye (Fig. 1). In 0.9-mm thickness
cut, T2-weighted magnetic resonance imaging with fast imaging
employing steady state acquisition (FIESTA) sequence at his sub-
arachnoid area, the proximal portion of the right trochlear nerve
could not be identiﬁed as compared to the visible nerve on the left
side (Fig. 2A). In 1-mm thickness cut, three-dimensional (3D) time
of ﬂight magnetic resonance angiography, the path of the right
medial superior cerebellar artery (SCA) was similar to the left
trochlear nerve identiﬁed in magnetic resonance imaging (Fig. 2B).
Although evidence of neurovascular compression of the right
trochlear nervewas not found, we started medical treatment under
the clinical diagnosis of SOM.
Oxcarbazepine, 600 mg/day, was prescribed and the symptoms
resolved. The patient remained symptom-free with no torsional
nystagmus observed during the follow-up period of 1 year.3. Discussion
SOM is an uncommon disorder characterized by brief episodes
of unilateral oscillopsia and/or diplopia. The term was introduced
by Hoyt and Keane6 in 1970. The associated symptoms are thought
to be caused by abnormal electrical activity of the trochlear nerve
and twitching of the superior oblique muscle, leading to intorsionalan. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Motility examination showed right hypertropia at primary position and mild over-elevation in adduction in the right eye of the patient. The patient had torsional oscillopsia
especially in the ﬁeld of gaze of the right superior oblique muscle.
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abnormal activity of the trochlear nerve remains unconﬁrmed. One
of the postulated hypotheses to explain the associated pathology
is vascular compression of the cistern segment of the trochlear
nerve, leading to damage of the area between the central and
peripheral myelin, which is particularly vulnerable to pulsatile
pressure, causing abnormal muscle twitching as in hemi-facial
spasm.7 The long intracranial course (60 mm) and narrow diame-
ter (0.2e0.6 mm)8,9 of the trochlear nerve makes it fragile and
easily affected by surrounding structures.
Imaging the cistern segment of the trochlear nerve has been a
challenge because of its small diameter. The proximity of the
trochlear nerve to nearby vessels taking a similar course and with
similar caliber has also increased the difﬁculty in determining the
speciﬁc neurovascular relationships. Casselman et al10 postulated
3D constructive interference in steady state (CISS) magnetic reso-
nance imaging with a section thickness of 0.7 mm to image the
cisternal portion of the trochlear nerve in 1994. Yousry et al11
successfully depicted the anatomy of the trochlear nerve in 30
volunteers and a patient with SOM using 0.66-mm thickness
magnetic resonance imaging with 3D CISS sequences. The detec-
tion rate was highest at transverse plane, reaching 95% among the
60 nerves imaged. With utilization of 3D balanced turbo ﬁeld echo
sequence at the pontomesencephalic junction, section thickness of
0.25 mm, Yang et al12 described the detailed anatomy of theFig. 2. (A) Magnetic resonance imaging with fast imaging employing steady state acquisiti
subarachnoid area of the patient with SOM. The cut thickness was 0.9 mm (TE 5.47). The l
(arrows) can be seen. The right medial SCA is overlapped at the root exit zone and righ
(B) One-mm cut, 3D transverse time of ﬂight magnetic resonance angiogram (TE 7.2) conﬁcisternal segment of the trochlear nerve in 97 superior oblique
palsy patients. One of the reasons that we failed to identify neu-
rovascular contact might be the effective section thickness used.
We scanned the patient with cut thickness of 0.9 mm, which was
more than 0.7 mm suggested by a previous study.10 However,
neurovascular contact is not a marker for diagnosing SOM because
it is not a rare anatomic phenomenon. Abducens nerve was found
to be in contact with the anterior inferior cerebellar artery in 76.6%
of cases in a magnetic resonance imaging study.13 Yousry et al11
found that medial SCA branches were in direct contact with 51%
of the trochlear nerve identiﬁed. At present, diagnosis of SOM still
mainly depends on clinical symptoms and signs.
Various medications have been used to treat SOM. Carbamaze-
pine, a neural membrane stabilizing agent, is the most frequently
administered medication. Its use has shown promising treatment
results.3,14,15, Beneﬁts from phenytoin, baclofen, propranolol, and
clonazepam have also been reported.16,17 Williams et al3 reported
that 15 out of 18 (83%) patients with SOM beneﬁted from carbama-
zepine, 400 mg/day, titrated to 800 mg/day as tolerated. Six patients
(30%) stopped treatment because of adverse effects such as rash,
elevated liver enzyme, mild nausea, and/or lethargy. Surgical treat-
ments are alternatives when medical treatment is unsuccessful.
Surgery of the extraocular muscles with the combination of superior
oblique tenectomy and inferior obliquemyectomy has been reported
to be effective in eliminating oscillopsia associated with SOM;on (FIESTA) sequence, constructive interference in steady state (CISS) T2 image, in the
eft trochlear nerve (arrowhead) and medial superior cerebellar artery (SCA) branches
t trochlear nerve cannot be clearly distinguished from the artery on the right side.
rmed that the structure at the root entry zone is an artery (arrow).
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36% of patients.4 Although treatment success has been reported,5 the
risks of intracranial microvascular decompression surgery probably
outweigh the beneﬁts in most cases.
Oxcarbazepine is a derivative of carbamazepine. It is a pro-drug
and is activated to eslicarbazepine in the liver.18 Like carbamaze-
pine, it works as an inhibitor of the voltage-dependent sodium
channel and decreases the excitability of the cell membrane. The
structural differences from carbamazepine reduce the metabolic
effects on the liver and decreases hematological side effects occa-
sionally associated with carbamazepine. The patient reported here
responded well to oxcarbazepine and was symptom-free without
adverse effects at 1 year follow-up.
In conclusion, a rare case of SOM is reported without deﬁnite
imaging evidence of neurovascular contact. With diagnosis based
upon clinical presentations, visual symptoms can be successfully
treated with oxcarbazepine.References
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